Login

Username

Enter your Progress In Mind Portugal username.

Password

Enter the password that accompanies your username.

Request new password

Progress in Mind Portugal

Topics
Congress highlights
- EAN 2022
- AAN 2022
- AHS 2022
- AAN 2021
- AHS 2021
- IHC 2021
- SIRS 2019
- EPA 2019
- EPA 2018
- APA 2018
- ECNP 2017
About
Podcasts
Newsletter signup

Search

Search

Main navigation

Home
Lundbeck Therapeutic Area Australia
Progress in Mind Korea Focus Area
Progress in Mind Spain Focus Area
전문가 칼럼
찾아보기

Tools

찾아보기
User Profile

User account menu

Log in

Username

Password

Reset your password

Powered by Drupal

Search

The information on this site is exclusively intented for health care professionals.

Accept Decline

Progress in Mind Portugal

Your Psychiatry & Neurology Resource Center

COVID-19

ECNP 21

Medical education resource center

Do you want to learn more?

Medical education resource center

The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology.

THINC®

Focus on cognitive symptoms in depression

Recent News

All
Depression
Migraine
Schizophrenia

Migraine 09 Aug, 2021 Read Time: 3 mins

Congress highlights

Does migraine alter COVID-19 susceptibility?

In a late-breaking abstract presentation at #AHSAM21, Professor Robert Shapiro, University of...
Schizophrenia 30 Jul, 2021 Read Time: 4 mins

Congress highlights

From clinic to community – insights on successful early psychosis management programs

In the USA, OnTrackNY and the Early Psychosis Intervention NETwork (EPINET) are different parts of a...
Bipolar 26 Jul, 2021 Read Time: 3 mins

Satellite symposium

Can early intervention prevent progressive loss of brain and cognitive capacity?

Given imaging and cognitive science evidence that bipolar disorder is neuroprogressive, early...
Depression 26 Jul, 2021 Read Time: 2 mins

Article

What are the implications of childhood trauma for depression and its response to therapy?

Childhood trauma is an important risk factor for major depressive disorder (MDD).1 It is...
Schizophrenia 26 Jul, 2021 Read Time: 3 mins

Congress highlights

Patients at high risk for psychosis pose a clinical dilemma

The concept of a clinical high risk syndrome for psychosis is justified not only by the fact that...
Schizophrenia 26 Jul, 2021 Read Time: 3 mins

Congress highlights

Digital technology may support sustained long-term recovery in first episode psychosis

Evolving technology can offer people with first episode psychosis personalized treatment when they...
Mental Health 26 Jul, 2021 Read Time: 3 mins

Congress highlights

Assess outcomes meaningful to patients to improve care equity and quality

Ensuring that optimum healthcare is open to all - irrespective of gender, ethnicity and social and...
Mental Health 26 Jul, 2021 Read Time: 3 mins

Congress highlights

Psychosis in dementia or dementia in psychosis? A clinical approach to a common puzzle

Overlapping and interacting problems of late-life psychosis, depression and cognitive decline –...
Alzheimer's Disease 26 Jul, 2021 Read Time: 3 mins

Satellite symposium

Challenges and opportunities in early diagnosis and prevention

Mixed dementia etiologies, and neuropsychiatric symptoms that overlap cognitive deficits illustrate...
Mental Health 26 Jul, 2021 Read Time: 3 mins

Congress highlights

The pandemic has permanently changed psychiatry, but perhaps not radically

That was the slightly nuanced overall verdict from the debate. While 93% of the online audience...

Pagination

First page
Previous page
…
Page 6
Page 7
Current page 8
Page 9
Page 10
…
Next page
Last page

Depression 15 May, 2018 Read Time: 3 mins

Congress highlights

Psychotic depression – From biology to the clinic

Psychotic depression may develop in response to a major traumatic event; such as bereavement or...
Depression 17 Jan, 2018 Read Time: 2 mins

Article

Don’t waste time

At ECNP 2017, Prof Hamish McAllister-Williams, Newcastle University, UK, provided an in-depth review...
Depression 27 Nov, 2017 Read Time: 1 min

Article

Light in the darkness: Combating the mid-winter blues

Social, cultural, and even climatic factors can make the winter holidays particularly difficult for...
Depression, Schizophrenia 13 Sep, 2017 Read Time: 3 mins

Congress highlights

Sexual side-effects – let’s talk!

Sexual side-effects, sometimes experienced by patients during treatment, are not only debilitating...
Depression 08 Sep, 2017 Read Time: 5 mins

Congress highlights

Successful screening

At ECNP 2017, an expert science exchange explored evidence of the link between cognitive dysfunction...
Depression 05 Sep, 2017 Read Time: 4 mins

Satellite symposium

Remission of depression from the patient’s perspective

Clinicians say a person is in remission, but would that patient agree? What do patients look for in...
Depression 04 Sep, 2017 Read Time: 7 mins

Συνέδριο

Cuando caemos, ¿podemos levantarnos de nuevo?

Los episodios depresivos mayores a menudo incapacitan funcionalmente al paciente, incluso después de...
Mental Health 07 Mar, 2017 Read Time: 8 mins

Feature

Genetic and Environmental Impact on Psychiatric and Neurological Disease
Depression 30 Aug, 2015 Read Time: 3 mins

Interview

Not magic but logic

An interview with Professor Michael Thase, Director of the Mood and Anxiety Program at the University...
Depression 30 Mar, 2015 Read Time: 4 mins

Congress highlights

Serotonin is good for you … or is it? The multifarious effects of stimulation and depletion

Pagination

First page
Previous page
…
Page 5
Page 6
Page 7
Current page 8
Page 9
Next page
Last page

Migraine 20 Jan, 2021

Podcast

Impact of migraine on patients: Risks of getting MoH

Migraine negatively impacts on virtually all aspects of life and severe forms affect up to 2% of the...
Migraine 20 Jan, 2021

Podcast

When the treatment becomes the problem: MoH

Medication overuse headache (MOH) often occurs when patients self-medicate to alleviate acute...
Migraine 15 Jan, 2021 Read Time: 3 mins

Congress highlights

Preventing migraine: finding the right approach

Preventative treatment of migraine is underused and should be considered when patients have frequent...
Migraine 12 Jan, 2021 Read Time: 2 mins

Congress highlights

Chi dovrebbe sottoporsi a un trattamento preventivo dell'emicrania e quanto sono efficaci queste terapie?

La terapia preventiva dell'emicrania viene utilizzata per ridurre la frequenza, la durata o la...
Migraine 30 Dec, 2020 Read Time: 2 mins

Congress highlights

Spotlight on CGRP sites of action in migraine

Monoclonal antibodies targeting calcitonin gene-related peptide show good efficacy as preventive...
Migraine 22 Dec, 2020

Podcast

Educating the patient aids effective treatment of migraine

Teaching the patient about their brain can truly make a difference in their engagement with...
Migraine 18 Dec, 2020

Podcast

CGRP – new perspectives in headache management

Three new takes on the potential for calcitonin gene-related proteins were presented at this year’s...
Migraine 09 Dec, 2020 Read Time: 2 mins

Congress highlights

Preventive therapy reduces interictal burden of migraine

The impact of migraine on a person’s life is multi-faceted; not only is there substantial functional...
Migraine 08 Dec, 2020 Read Time: 3 mins

Article

Midwinter migraine: is weather more important than chocolate?

Indulgence in food and alcohol, dehydration, sleep disturbance, and stress associated with...
Migraine 27 Nov, 2020 Read Time: 3 mins

Congress highlights

When is a migraine not a migraine?

If a patient with migraine develops a thunderclap headache or experiences a change in aura, is the...

Pagination

First page
Previous page
…
Page 6
Page 7
Current page 8
Page 9
Page 10
…
Next page
Last page

Schizophrenia 15 Apr, 2019 Read Time: 4 mins

Article

Early detection and intervention in psychosis – where are we now?

Many of those experiencing first-episode psychosis achieve clinical remission, but often with poor...
Schizophrenia 15 Apr, 2019 Read Time: 3 mins

Article

Biomarkers - the Future of Diagnosis in Psychiatry?

Diagnosis of psychiatric disorders currently depends on clinical criteria. In the future the hope is...
Schizophrenia 03 Apr, 2019 Read Time: 4 mins

Article

Positive steps to address negative symptoms in schizophrenia

A goal of precision psychiatry is to locate a patient along the continuum of the disease course,...
Schizophrenia 01 Apr, 2019 Read Time: 2 mins

Article

Long-acting injectable or oral antipsychotic for first episode psychosis?

Antipsychotic therapy improves outcomes for patients with first episode of psychosis, yet a study...
Schizophrenia 06 Mar, 2019 Read Time: 4 mins

Article

The effects of antipsychotic dose reduction/discontinuation on long-term outcome in FEP patients

Patients with FEP often ask whether they can discontinue their medication after a period of...
Schizophrenia 27 Feb, 2019 Read Time: 3 mins

Article

Treatment-resistant schizophrenia — mechanisms, awareness, and economic burden

One-third of individuals with schizophrenia develop treatment-resistant schizophrenia (TRS); and...
Schizophrenia 21 Feb, 2019 Read Time: 5 mins

Article

Changing the course of schizophrenia: biology, psychology and livelihood

How to manage and mitigate some long-term problems associated with schizophrenia, and improve...
Schizophrenia 12 Feb, 2019 Read Time: 4 mins

Article

Complementary approaches for improving outcomes in first-episode psychosis

Early intervention (EI) services are designed to improve outcomes in patients with first episode...
Schizophrenia 07 Feb, 2019 Read Time: 1 min

Article

Early use of a long acting injectable antipsychotic shortens hospital stay for acute schizophrenia

Average hospital stay for patients treated with a long-acting injectable (LAI) antipsychotic...
Schizophrenia 06 Feb, 2019 Read Time: 4 mins

Article

Refining and redefining diagnosis and prognosis in psychosis: can biomarkers and imaging help?

Consortia the world over are seeking biomarkers, including abnormalities on brain imaging, that...

Pagination

First page
Previous page
…
Page 6
Page 7
Current page 8
Page 9
Page 10
…
Next page
Last page

Most Popular

Depression

12 May, 2023

Que experiência têm os profissionais de saúde com a utilização da dose de 20 mg de Brintellix® para tratar os seus doentes com TDM?

Progress in Mind Portugal HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Portugal click here.

Continue to verification page Login with email

Brought to you by

© 2021

PROGRESS IN MIND PORTUGAL

Condições de Utilização

subscribe newsletter

Sign up for newsletter

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue

By submitting this form you agree that your email is sent to a third party for validation.

Read the full terms and conditions here.